Viveve Medical, Inc. (VIVE)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Oct 23, 2025, 8:00 PM EDT
Viveve Medical Market Cap
Viveve Medical has a market cap or net worth of $1.08 thousand as of October 24, 2025. Its market cap has decreased by -93.32% in one year.
Market Cap
1.08K
Enterprise Value
n/a
Revenue
6.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 27, 2013, Viveve Medical's market cap has decreased from 508.17B to 1.08K, a decrease of -100.00%. That is a compound annual growth rate of -80.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 1.08K | -49.88% |
| Dec 31, 2024 | 2.15K | - |
| Dec 29, 2023 | 2.15K | -99.95% |
| Dec 30, 2022 | 4.56M | -62.29% |
| Dec 31, 2021 | 12.09M | 18.44% |
| Dec 31, 2020 | 10.21M | 101.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 633.13M |
| Glass House Brands | 618.32M |
| Silence Therapeutics | 342.45M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 319.35M |
| Northwest Biotherapeutics | 305.00M |
| American Oncology Network | 297.14M |